Arun Pawar
Arun Pawar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Monika Ola
Department of Pharmaceutics, R. C. Patel Institute of Pharmacy, Shirpur, Dhule, Maharashtra, India 425405
4 shared publications - Rajveer Bhaskar
Department of Industrial Pharmacy, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule Maharashtra, India 425405
4 shared publications - Rohini Tikhe
Department of Pharmaceutics, R. C. Patel Institute of Pharmacy, Shirpur, Dhule, Maharashtra, India 425405
4 shared publications - Shivani Khade
Department of Pharmaceutics, R. C. Patel Institute of Pharmacy, Shirpur, Dhule, Maharashtra, India 425405
4 shared publications - Sunil Shinde
Department of Pharmaceutics, R. C. Patel Institute of Pharmacy, Shirpur, Dhule, Maharashtra, India 425405
4 shared publications - Vaishnavi Madwe
Department of Pharmaceutics, R. C. Patel Institute of Pharmacy, Shirpur, Dhule, Maharashtra, India 425405
4 shared publications
Latest Publications
- Open Access
- 15 August 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (8) , 315-326
Advancements, Challenges, and Future Directions in Biosensor Technology for Healthcare and Diagnostics
Biosensors are transforming healthcare by enabling faster, more cost-effective, and less invasive methods for disease detection, monitoring, and personalized therapy. In the future, these devices are expected to facilitate real-time data collection as replacements for traditional testing methods, which can be complex and invasive. However, the widespread adoption of biosensors in clinical practice is currently limited by several challenges. Key issues include thermal instability, variability in performance, interference from complex biological environments, and difficulties in integrating these technologies within existing healthcare systems. Additionally, the high production costs and the absence of standardized regulatory guidelines for everyday healthcare applications pose significant barriers. Recent advances in nanotechnology, artificial intelligence (AI), and stem-cell-based biosensors may help address some of these challenges. Nanomaterials like carbon nanotubes and gold nanoparticles enhance the sensitivity and specificity of biosensors. Moreover, AI-driven applications can facilitate real-time data interpretation and decision-making, while stem-cell-based biosensors offer a promising new avenue for achieving realistic in vivo responses in disease detection and drug screening. Despite these advancements, challenges such as miniaturization, ensuring safe use, biocompatibility of new materials, and data security still need to be overcome. However, as research progresses, biosensors are likely to become recognized for early disease detection, health monitoring, and personalized treatment. Continuous improvements in biosensors will enhance their credibility, make them more cost-effective, and increase their accessibility, ultimately leading to better health outcomes. Keywords: Biosensor in Healthcare, Its advancement and Challenges.
- 15 August 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (8) , 315-326
Open AccessAdvancements, Challenges, and Future Directions in Biosensor Technology for Healthcare and Diagnostics
Biosensors are transforming healthcare by enabling faster, more cost-effective, and less invasive methods for disease detection, monitoring, and personalized therapy. In the future, these devices are expected to facilitate real-time data collection as replacements for traditional testing methods, which can be complex and invasive. However, the widespread adoption of biosensors in clinical practice is currently limited by several challenges. Key issues include thermal instability, variability in performance, interference from complex biological environments, and difficulties in integrating these technologies within existing healthcare systems. Additionally, the high production costs and the absence of standardized regulatory guidelines for everyday healthcare applications pose significant barriers. Recent advances in nanotechnology, artificial intelligence (AI), and stem-cell-based biosensors may help address some of these challenges. Nanomaterials like carbon nanotubes and gold nanoparticles enhance the sensitivity and specificity of biosensors. Moreover, AI-driven applications can facilitate real-time data interpretation and decision-making, while stem-cell-based biosensors offer a promising new avenue for achieving realistic in vivo responses in disease detection and drug screening. Despite these advancements, challenges such as miniaturization, ensuring safe use, biocompatibility of new materials, and data security still need to be overcome. However, as research progresses, biosensors are likely to become recognized for early disease detection, health monitoring, and personalized treatment. Continuous improvements in biosensors will enhance their credibility, make them more cost-effective, and increase their accessibility, ultimately leading to better health outcomes. Keywords: Biosensor in Healthcare, Its advancement and Challenges.
- Open Access
- 15 May 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (5) , 194-206
Current and Emerging Formulations in Topical Antifungal Therapy: A Comparative Overview
Fungal infections, a widespread issue, affect millions of people worldwide and can range from minor skin diseases to serious, sometimes fatal infections. Traditional topical treatments, such as creams, gels, sprays, and ointments, are popular for treating fungal infections due to their ease of use, fewer adverse effects, and safety. However, they have drawbacks like frequent application, inability to stay on the skin for extended periods, and uneven efficacy. New drug delivery technologies, such as liposomes, nanoparticles, and microemulsions, are transforming the treatment of fungal diseases by improving drug interaction with the skin, enhancing patient comfort, and reducing side effects. Keywords: Fungal infections, Topical antifungal therapy, Nanotechnology, Therapeutic efficacy.
- 15 May 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (5) , 194-206
Open AccessCurrent and Emerging Formulations in Topical Antifungal Therapy: A Comparative Overview
Fungal infections, a widespread issue, affect millions of people worldwide and can range from minor skin diseases to serious, sometimes fatal infections. Traditional topical treatments, such as creams, gels, sprays, and ointments, are popular for treating fungal infections due to their ease of use, fewer adverse effects, and safety. However, they have drawbacks like frequent application, inability to stay on the skin for extended periods, and uneven efficacy. New drug delivery technologies, such as liposomes, nanoparticles, and microemulsions, are transforming the treatment of fungal diseases by improving drug interaction with the skin, enhancing patient comfort, and reducing side effects. Keywords: Fungal infections, Topical antifungal therapy, Nanotechnology, Therapeutic efficacy.
- Open Access
- 15 May 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (5) , 181-193
Eye Drops to smart gels: The future of ocular drug delivery
This review paper assesses traditional and modern methods to enhance ocular drug delivery. Various techniques available to administer drugs include topical application, intracameral injections, intravitreal injections, and subconjunctival injections. In Addition, this review discusses eye anatomy and the associated challenges with effectively delivering medications to this organ. It emphasizes recent progress in Ophthalmic drug delivery methods, such as on-situ gel systems, nanoparticles, liposomes, and dendrimers, which improve drug retention, bioavailability, and therapeutic efficacy. The article also explores potential improvements in drug delivery for treating eye disorders by utilizing nanotechnology and stimulus-responsive gels to improve patient outcomes. The goal is to achieve targeted and continuous release. Keywords: Ocular drug delivery, in-situ gel, nano formulation, prolonged release
- 15 May 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (5) , 181-193
Open AccessEye Drops to smart gels: The future of ocular drug delivery
This review paper assesses traditional and modern methods to enhance ocular drug delivery. Various techniques available to administer drugs include topical application, intracameral injections, intravitreal injections, and subconjunctival injections. In Addition, this review discusses eye anatomy and the associated challenges with effectively delivering medications to this organ. It emphasizes recent progress in Ophthalmic drug delivery methods, such as on-situ gel systems, nanoparticles, liposomes, and dendrimers, which improve drug retention, bioavailability, and therapeutic efficacy. The article also explores potential improvements in drug delivery for treating eye disorders by utilizing nanotechnology and stimulus-responsive gels to improve patient outcomes. The goal is to achieve targeted and continuous release. Keywords: Ocular drug delivery, in-situ gel, nano formulation, prolonged release
- Open Access
- 15 April 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (4) , 150-164
Oral Thin Films: A Modern Frontier in Drug Delivery Systems
Oral thin films (OTFs) are gaining popularity in the pharmaceutical industry for their advantages over traditional oral dosage forms, especially for patients with swallowing difficulties, such as children and the elderly. OTFs provide a discreet, convenient, and fast-acting method of drug administration. They dissolve quickly in saliva, enabling rapid absorption through the oral mucosa, bypassing first-pass metabolism and enhancing bioavailability, which can reduce required doses and side effects. OTFs are particularly useful for poorly soluble drugs and allow for precise dosing, making them ideal for pediatric patients. They can also mask unpleasant tastes, improving patient acceptance. Research on OTFs is expanding, with innovations like pH-sensitive films, micro-pellet-loaded films, and the potential for delivering vaccines and probiotics. The OTF market is projected to reach $7.65 billion by 2028, growing at a 13.6% CAGR. Future developments focus on personalized OTFs, made possible by printing technologies like inkjet and 3D printing, offering tailored dosing and drug combinations. OTFs hold great promise to revolutionize drug delivery, benefiting both patients and healthcare providers. Key words: Oral thin film, Pediatric and geriatric drug dosing, market growth of OTF, Technologies of preparation of film
- 15 April 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (4) , 150-164
Open AccessOral Thin Films: A Modern Frontier in Drug Delivery Systems
Oral thin films (OTFs) are gaining popularity in the pharmaceutical industry for their advantages over traditional oral dosage forms, especially for patients with swallowing difficulties, such as children and the elderly. OTFs provide a discreet, convenient, and fast-acting method of drug administration. They dissolve quickly in saliva, enabling rapid absorption through the oral mucosa, bypassing first-pass metabolism and enhancing bioavailability, which can reduce required doses and side effects. OTFs are particularly useful for poorly soluble drugs and allow for precise dosing, making them ideal for pediatric patients. They can also mask unpleasant tastes, improving patient acceptance. Research on OTFs is expanding, with innovations like pH-sensitive films, micro-pellet-loaded films, and the potential for delivering vaccines and probiotics. The OTF market is projected to reach $7.65 billion by 2028, growing at a 13.6% CAGR. Future developments focus on personalized OTFs, made possible by printing technologies like inkjet and 3D printing, offering tailored dosing and drug combinations. OTFs hold great promise to revolutionize drug delivery, benefiting both patients and healthcare providers. Key words: Oral thin film, Pediatric and geriatric drug dosing, market growth of OTF, Technologies of preparation of film